WindRose Health Investors completed the investment in Stellus Rx.

WindRose Health Investors, a healthcare-focused private equity firm, completed the investment in Stellus Rx, a company that offers pharmacy expertise and solutions aimed at improving health outcomes. Financial terms were not disclosed. "This partnership with WindRose marks a significant milestone for Stellus Rx, as we continue to scale our pharmacist-led platform and ensure that even more people receive the full benefit and value from their prescribed medications. WindRose's deep healthcare expertise and collaborative approach make them an ideal partner. We look forward to our work together, as we continue to help millions of people achieve better health outcomes through a fully supported medication experience," Tony Willoughby, Stellus Rx CEO.